Log in
Enquire now
Atossa Genetics, Inc.

Atossa Genetics, Inc.

A drug company developing therapeutics and delivery methods for breast cancer and other breast conditions

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/atossa-genetics
B2X
B2B
B2B
CEO
Steven Quay
Steven Quay
CIK Number
1,488,039
Company Operating Status
Active
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...genetics
Facebook URL
@Atossa-Genetics-280152312040
Founded Date
January 1, 2009
Founder
Steven Quay
Steven Quay
Full Address
1616 Eastlake Ave E, Suite 201, Seattle, WA 98102, US
107 Spring Street Seattle, WA 98104
0
Headquarters
Seattle
Seattle
0
Industry
Consumer biotechnology
Consumer biotechnology
Genetics
Genetics
Healthcare
Healthcare
Medical device
Medical device
Cancer
Cancer
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Health technology
Health technology
Investors
Aspire Capital Partners LLC
Aspire Capital Partners LLC
Keiretsu Forum Northwest / Rockies
Keiretsu Forum Northwest / Rockies
IRS Number
264,753,208
Latest Funding Round Date
May 2015
Latest Funding Type
‌
Venture round
LinkedIn URL
@company/atossa-genetics-inc-
Location
Seattle
Seattle
0
Named After
Atossa
Atossa
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
2
Place of Incorporation
Delaware
Delaware
SIC Code
3,841
Exchange
Nasdaq
Nasdaq
Stock Symbol
ATOS
Total Funding Amount (USD)
32,600,000
Twitter URL
@AtossaGenetics
Official Website
atossagenetics.com
Wellfound ID
atossa-genetics
Wikidata ID
Q17513939

Find more companies like Atossa Genetics, Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.